Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INDUCING REMISSION IN MELANOMA PATIENTS WITH CHECKPOINT INHIBITOR THERAPY USING FECAL MICROBIOTA TRANSPLANTATION.

NCT04577729 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04577729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04577729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INDUCING REMISSION IN MELANOMA PATIENTS WITH CHECKPOINT INHIBITOR THERAPY USING FECAL MICROBIOTA TRANSPLANTATION.
Lead sponsor
Medical University of Graz
Phase
Not applicable
Overall status
Terminated
Start date
May 21, 2021
Completion date
June 7, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal microbiota transplantation, malignant melanoma stage iii, malignant melanoma stage iv